OpenSAFELY: impact of national guidance on switching anticoagulant therapy during COVID-19 pandemic

BACKGROUND: Early in the COVID-19 pandemic, the National Health Service (NHS) recommended that appropriate patients anticoagulated with warfarin should be switched to direct-acting oral anticoagulants (DOACs), requiring less frequent blood testing. Subsequently, a national safety alert was issued re...

Descripción completa

Detalles Bibliográficos
Autores principales: Curtis, Helen J, MacKenna, Brian, Walker, Alex J, Croker, Richard, Mehrkar, Amir, Morton, Caroline, Bacon, Seb, Hickman, George, Inglesby, Peter, Bates, Chris, Evans, David, Ward, Tom, Cockburn, Jonathan, Davy, Simon, Bhaskaran, Krishnan, Schultze, Anna, Rentsch, Christopher T, Williamson, Elizabeth, Hulme, William, Tomlinson, Laurie, Mathur, Rohini, Drysdale, Henry, Eggo, Rosalind M, Wong, Angel Yun, Forbes, Harriet, Parry, John, Hester, Frank, Harper, Sam, Douglas, Ian, Smeeth, Liam, Goldacre, Ben
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Health Care Delivery, Economics and Global Health Care
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8595296/
https://www.ncbi.nlm.nih.gov/pubmed/34785588
http://dx.doi.org/10.1136/openhrt-2021-001784

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8595296/
https://www.ncbi.nlm.nih.gov/pubmed/34785588
http://dx.doi.org/10.1136/openhrt-2021-001784

Ejemplares similares